Irvine, Calif., Feb. 20, 2014 — Sue and Ralph Stern have made a $5 million gift to UC Irvine, establishing the Sue and Ralph Stern Center for Cancer Clinical Trials and Research at the Chao Family Comprehensive Cancer Center, which is part of UC Irvine Health. The cancer center is Orange County’s only National Cancer Institute-designated […]
Levels of contaminants higher than in some of the world’s most polluted cities have been found downwind of Canada’s largest oil, gas and tar sands processing zone, in a rural area where men suffer elevated rates of cancers linked to such chemicals.
Lari Wenzel, UC Irvine professor of medicine and public health, has received a $1.9 million from the Patient-Centered Outcomes Research Institute to create and study the use of a new, personalized approach to shared treatment decision-making for newly diagnosed ovarian cancer patients.
Device used during breast cancer surgery permits surgeon to determine whether the entire tumor was removed.
Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published today in the Journal of the American Chemical Society.
UC Irvine biologists, chemists and computer scientists have identified an elusive pocket on the surface of the p53 protein that can be targeted by cancer-fighting drugs. The finding heralds a new treatment approach, as mutant forms of this protein are implicated in nearly 40 percent of diagnosed cases of cancer, which kills more than half a million Americans each year.
Experimental vaccine trains immune system to target remaining tumor cells after surgery, chemo
Experiemental vaccines hold promise to slow the return of glioblastoma multiforme. UC Irvine begins enrolling patients in DCVax trial.
Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option that lengthens their lives, according a study led by UCI oncologist Dr. Rita Mehta and conducted by the Southwest Oncology Group.
UC Irvine’s Dr. Robert Bristow finds that African American women and poor women with ovarian cancer have lower survival rates and receive lower standard of care.